How to Buy Arvinas Stock
Arvinas Inc
Arvinas, Inc. , a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins.
Arvinas stock last closed at $34.00, down 2.58% from the previous day, and has increased 24.5% in one year. It has overperformed other stocks in the Biotechnology industry by 0.48 percentage points. Arvinas stock is currently +150.55% from its 52-week low of $13.57, and -35.95% from its 52-week high of $53.08.
At the moment, there are 68.08M ARVN shares outstanding. The market capitalization of ARVN is $2.31B. In the past 24 hours, 527,952 ARVN shares were traded.
How to Buy Arvinas Stock
Not sure how to invest in Arvinas stock? Here's how.
- Figure out where to buy Arvinas stock: You need to decide on an online brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you figure out where to buy Arvinas stock.
- Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Deposit money your brokerage account: Select your method of payment and add your details.
- Research Arvinas stock: The Arvinas ticker symbol is ARVN. Is Arvinas stock a good investment? Should you buy shares of ARVN? How do ARVN's underlying business fundamentals look? Do top analysts think Arvinas is a good buy? Why has ARVN's stock price moved recently? (Hint: Our stock research tools can help you figure out if ARVN is a good stock to buy).
- Execute your ARVN buy order: Decide if you will purchase ARVN shares at the current market price or use a limit order to buy ARVN shares at a given price.
- Monitor your investment in ARVN: Create a watchlist to the latest updates on your investment in Arvinas shares.
Step 1: Figure out where to buy Arvinas stock
You need a brokerage account in order to access the NASDAQ market and buy ARVN stock.
Our recommended brokerage: eToro
Based on our experience, eToro is the best brokerage. eToro gives you:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to world financial markets: From Tech to Healthcare, New York to Shanghai — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro offers a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by creating an account with eToro today.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've selected the right brokerage, it's time to fill out some personal information so you can invest in ARVN today.
How to Create a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to open your new trading account.
- Send your data by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you've filled out your info on the best stock investing app, you can securely and quickly fund your account:
Watch the tutorial below to see the process of depositing funds into your brokerage account.
Step 4: Research Arvinas stock
Once you have chosen the best place to buy Arvinas stock, it's important to research their stock prior to buying, so you actually comprehend the risk and opportunity.
Arvinas shares data
Arvinas Zen Score
WallStreetZen was built to help everyday investors perform more in-depth fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on ARVN's stock page.
Is ARVN stock overvalued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge ARVN's true value.
Using relative valuations methods:
- ARVN could be undervalued based on its P/B ratio of 3.51x, relative to Biotechnology industry P/B ratio of 5.93x
You can do more valuation analysis on ARVN's stock here.
A look at ARVN Cashflows and Balance Sheet
Passed Financial Due Diligence Checks:
- There are more short-term assets than short-term liabilities on the ARVN balance sheet.
- There are more short-term assets than long-term liabilities on the ARVN balance sheet.
- ARVN has cash burn of 350700000. It has enough cash and short-term investments to cover this for at least one year.
- ARVN has $1.27B in cash and short term investments. This is sufficient to cover its annual cash burn of $350.70M.
Failed Financial Due Diligence Checks:
- Total ARVN debt is higher than 5 years ago, relative to shareholder equity.
- ARVN has a relatively high debt to equity ratio of 0.98.
- ARVN profit margin has gone down from -215% to -467.9% in the past year.
Is ARVN stock a Buy, Hold, or Sell, according to analysts?
Out of 13 Equities analysts who give forecasts on ARVN, the consensus analyst rating on ARVN is a Strong Buy
It's important to note that analyst ratings are not recommendations, nor are they investment advice.
Most Recent ARVN Analyst Ratings
Matthew Biegler, a bottom 12% analyst from Oppenheimer reiterates ARVN with a buy rating and lowers their ARVN price target from $95.00 to $80.00, on Feb 28, 2024.
Yigal Nochomovitz, a top 7% analyst from Citigroup downgrades ARVN to a hold rating and raises their ARVN price target from $36.00 to $55.00, on Feb 15, 2024.
Paul Choi, a bottom 11% analyst from Goldman Sachs initiates coverage on ARVN with a strong buy rating and announces their ARVN price target of $70.00, on Feb 1, 2024.
Derek Archila, a top 2% analyst from Wells Fargo upgrades ARVN to a strong buy rating and announces their ARVN price target of $63.00, on Dec 19, 2023.
Akash Tewari, a top 25% analyst from Jefferies upgrades ARVN to a strong buy rating and raises their ARVN price target from $32.00 to $40.00, on Dec 6, 2023.
You can dive deeper into what analysts are projecting on the Arvinas stock forecast page.
ARVN Momentum
ARVN Revenue
Last year, ARVN revenue was $78.50M. In the last 5 year, ARVN's revenue has grown by 40.53% per year. This was faster than the Biotechnology industry average of 28.88%.
You can research ARVN's earnings and revenue performance here.
Are ARVN executives and large shareholders buying or selling the stock?
Over the last year, insiders at ARVN have sold more shares than they have bought.
Sean A. Cassidy, Chief Financial Officer of ARVN, was the latest ARVN insider to sell. They sold $80,079.10 worth of ARVN shares on Feb 23, 2024.
Research more about who owns ARVN stock here.
Can I get consistent income from ARVN stock?
No, Arvinas doesn't provide an income stream by paying out dividends.
Get opinions from other investors
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Execute your ARVN buy order
You have two main types of orders:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are mostly fine. - Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at an exact price limit, place a limit order.
Hit the Open button and your broker will execute your order.
If you need more help investing in stocks on eToro, watch the helpful video below:
Step 6: Monitor your investment in ARVN
Now that you own some ARVN stock, you'll want to stay up-to-date on your company.
Add ARVN to a watchlist to track your ARVN stock.
ARVN Feed
How to Buy Stock in Arvinas
To reiterate, here are the 6 steps to buy stock in Arvinas:
- Figure out where to buy Arvinas stock
- Sign up for a brokerage account
- Deposit money your brokerage account
- Research Arvinas stock
- Execute your ARVN buy order
- Monitor your investment in ARVN
If you need a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you want to get the latest scoop on your new investment in Arvinas, create your watchlist below.
Related Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.